1Learning Specific learning points 3. Number of cases with these 4. Action prompted 5. Action prompted Point Themes identified in each case themes (expressed as fraction of at practice level at cluster level the medication reviews – e.g. 4/15) Testing and Monitoring Evidence and Guidelines Adverse Events Risk Reduction or prevention Simplification or Switching
1Learning Point Themes Specific learning points identified in each case 3. Number of cases with these themes (expressed as fraction of the medication reviews – e.g. 4/15) 4. Action prompted at practice level 5. Action prompted at cluster level Testing and Monitoring Evidence and Guidelines Adverse Events Risk Reduction or prevention Simplification or Switching
5FinalPolypharmacyGuidance%202015.docx